|
-
- Non-surgical
oncology, including all chemotherapy and radiotherapy services for
Leicestershire, parts of Lincolnshire, North Northamptonshire and
East Warwickshire are provided at the Leicester Royal Infirmary.
Both inpatient and outpatient facilities for malignant
haematology and solid tumour oncology, as well as pain management
and palliative care services, are housed in the modern purpose-built
Osborne Building.
The Universities of Leicester and Warwick linked up in 2000 to form the
"Leicester Warwick Medical School" (LWMS), a venture which
will expand markedly over the coming years to become the largest
medical school in the country.
The Department of Oncology has a single chair serving both centres.
The merger increases the patient base to approximately 3 million, which will render this one of largest cancer centres in the UK.
Currently, there are approximately 5,000 new cases of cancer diagnosed per year in Leicestershire and increasing numbers are
entered into phase I/II/III clinical trials.
|
|
-
- At
its inception, the Department of Oncology established a Clinical
Trials Unit, including a portfolio of Phase I and II studies,
committed to the development of new approaches to cancer treatment
and prevention. A number of protocols have been completed, or are under development,
with collaborative groups under the auspices of Cancer Research UK (CRUK),
European Organisation for Research and Treatment of Cancer (EORTC)
and the pharmaceutical industry. A major strength of oncology
research in Leicester is the interaction of different groups within
the Departments of Oncology, Immunology, Biochemistry, Genetics,
Pathology and the MRC Toxicology Unit, all undertaking high quality
cancer-related laboratory-based research.
In addition to encouraging such links, one of the main aims of the academic
Department of Oncology has been to coordinate research and foster appropriate
translational components. One successful outcome has been the formation of the
CBPG.
|
|
